{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:35:16Z","timestamp":1769603716486,"version":"3.49.0"},"reference-count":33,"publisher":"Microbiology Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,5,1]]},"abstract":"<jats:p>In order to determine whether there is an association between the presence of Epstein\u2013Barr virus (EBV) and mycosis fungoides (MF) disease progression, PCR was performed to detect the EBV status of 20 MF patients; six EBV-positive patients were found. EBV variants may differ in their biological properties, such as their ability to transform cells; therefore, the ability of these variants to immortalize B cells<jats:italic>in vitro<\/jats:italic>was analysed. Six continuously growing cell lines were obtained from prolonged cultures of unstimulated peripheral blood mononuclear cells that were taken from the six EBV-positive patients with MF. In order to characterize the EBV strains, EBNA-2 and LMP-1\/LMP-2 gene polymorphisms in the six cell lines were also analysed. All patients were followed up for 10 years and it was noticed that EBV-positive patients had a poor prognosis with rapid disease progression and high mortality rates, compared to EBV-negative patients. EBV may therefore constitute a co-factor that accelerates the progression of disease.<\/jats:p>","DOI":"10.1099\/jmm.0.05439-0","type":"journal-article","created":{"date-parts":[[2004,4,19]],"date-time":"2004-04-19T22:35:45Z","timestamp":1082414145000},"page":"381-387","source":"Crossref","is-referenced-by-count":5,"title":["Polymorphism analysis of Epstein\u2013Barr virus isolates of lymphoblastoid cell lines from patients with mycosis fungoides"],"prefix":"10.1099","volume":"53","author":[{"given":"M. A.","family":"De Francesco","sequence":"first","affiliation":[{"name":"Institute of Microbiology, University of Brescia, Brescia, Italy 2Department of Dermatology, Spedali Civili, Piazzale Spedali Civili, 1, 25123 Brescia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Gargiulo","sequence":"additional","affiliation":[{"name":"Institute of Microbiology, University of Brescia, Brescia, Italy 2Department of Dermatology, Spedali Civili, Piazzale Spedali Civili, 1, 25123 Brescia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Esteban","sequence":"additional","affiliation":[{"name":"Institute of Microbiology, University of Brescia, Brescia, Italy 2Department of Dermatology, Spedali Civili, Piazzale Spedali Civili, 1, 25123 Brescia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. G.","family":"Calzavara-Pinton","sequence":"additional","affiliation":[{"name":"Institute of Microbiology, University of Brescia, Brescia, Italy 2Department of Dermatology, Spedali Civili, Piazzale Spedali Civili, 1, 25123 Brescia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Venturini","sequence":"additional","affiliation":[{"name":"Institute of Microbiology, University of Brescia, Brescia, Italy 2Department of Dermatology, Spedali Civili, Piazzale Spedali Civili, 1, 25123 Brescia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Perandin","sequence":"additional","affiliation":[{"name":"Institute of Microbiology, University of Brescia, Brescia, Italy 2Department of Dermatology, Spedali Civili, Piazzale Spedali Civili, 1, 25123 Brescia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Baronio","sequence":"additional","affiliation":[{"name":"Institute of Microbiology, University of Brescia, Brescia, Italy 2Department of Dermatology, Spedali Civili, Piazzale Spedali Civili, 1, 25123 Brescia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Pollara","sequence":"additional","affiliation":[{"name":"Institute of Microbiology, University of Brescia, Brescia, Italy 2Department of Dermatology, Spedali Civili, Piazzale Spedali Civili, 1, 25123 Brescia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Terlenghi","sequence":"additional","affiliation":[{"name":"Institute of Microbiology, University of Brescia, Brescia, Italy 2Department of Dermatology, Spedali Civili, Piazzale Spedali Civili, 1, 25123 Brescia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Manca","sequence":"additional","affiliation":[{"name":"Institute of Microbiology, University of Brescia, Brescia, Italy 2Department of Dermatology, Spedali Civili, Piazzale Spedali Civili, 1, 25123 Brescia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"345","reference":[{"key":"H1-5","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1365-2133.1996.tb07613.x","article-title":"Low incidence of Epstein-Barr virus presence in primary cutaneous T-cell lymphoproliferations","volume":"134","author":"Anagnostopoulos","year":"1996","journal-title":"Br J Dermatol"},{"key":"H2-5","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1023\/A:1008381006612","article-title":"The oncogenic 30 and 69 bp deletion variants of the EBV LMP-1 gene are common in HIV-negative lymphoproliferations, both malignant and benign","volume":"10","author":"Barozzi","year":"1999","journal-title":"Ann Oncol"},{"key":"H3-5","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1086\/314547","article-title":"Carboxy terminal variants of Epstein-Barr virus-encoded latent membrane protein 1 during long-term human immunodeficiency virus infection: reliable markers for individual strain identification","volume":"179","author":"Berger","year":"1999","journal-title":"J Infect Dis"},{"key":"H4-5","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.4049\/jimmunol.162.5.2555","article-title":"The EBV transforming protein, latent membrane protein 1, mimics and cooperates with CD40 signaling in B lymphocytes","volume":"162","author":"Busch","year":"1999","journal-title":"J Immunol"},{"key":"H5-5","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00000372-199806000-00005","article-title":"Detection of Epstein-Barr virus and HTLV-I in T-cell lymphomas of skin in Taiwan","volume":"20","author":"Chang","year":"1998","journal-title":"Am J Dermatopathol"},{"key":"H6-5","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/(SICI)1097-0215(19980504)76:3<399::AID-IJC18>3.0.CO;2-6","article-title":"Specific latent membrane protein 1 gene sequences in type 1 and type 2 Epstein-Barr virus from nasopharyngeal carcinoma in Hong Kong","volume":"76","author":"Cheung","year":"1998","journal-title":"Int J Cancer"},{"key":"H7-5","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/(SICI)1097-0215(19990129)80:3<356::AID-IJC4>3.0.CO;2-D","article-title":"Comparative analysis of Epstein-Barr virus gene polymorphism in nasal T\/NK-cell lymphomas and normal nasal tissues: implications on virus strain selection in malignancy","volume":"80","author":"Chiang","year":"1999","journal-title":"Int J Cancer"},{"key":"H8-5","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2340\/0001555574359360","article-title":"Presence of Epstein-Barr virus in cutaneous lesions of mycosis fungoides and S\u00e9zary syndrome","volume":"74","author":"Dreno","year":"1994","journal-title":"Acta Derm Venereol"},{"key":"H9-5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/viro.1997.8638","article-title":"Early detection of the lytic LMP-1 protein in EBV-infected B-cells suggests its presence in the virion","volume":"234","author":"Erickson","year":"1997","journal-title":"Virology"},{"key":"H10-5","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1128\/JVI.74.2.1057-1060.2000","article-title":"The late lytic LMP-1 protein of Epstein-Barr virus can negatively regulate LMP-1 signaling","volume":"74","author":"Erickson","year":"2000","journal-title":"J Virol"},{"key":"H11-5","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1128\/JVI.77.7.4415-4422.2003","article-title":"Unexpected absence of the Epstein-Barr virus (EBV) lyLMP-1 open reading frame in tumor virus isolates: lack of correlation between Met129 status and EBV strain identity","volume":"77","author":"Erickson","year":"2003","journal-title":"J Virol"},{"key":"H12-5","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1046\/j.1468-3083.2001.00309.x","article-title":"Examination of mycosis fungoides for the presence of Epstein-Barr virus and human herpesvirus-6 by polymerase chain reaction","volume":"15","author":"Erkek","year":"2001","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"H13-5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1006\/viro.1997.8690","article-title":"The immunoreceptor tyrosine-based activation motif of Epstein\u2013Barr virus LMP2A is essential for blocking BCR-mediated signal transduction","volume":"235","author":"Fruehling","year":"1997","journal-title":"Virology"},{"key":"H14-5","doi-asserted-by":"crossref","first-page":"7796","DOI":"10.1128\/JVI.72.10.7796-7806.1998","article-title":"Tyrosine 112 of latent membrane protein 2A is essential for protein tyrosine kinase loading and regulation of Epstein-Barr virus latency","volume":"72","author":"Fruehling","year":"1998","journal-title":"J Virol"},{"key":"H15-5","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0890-8508(90)90002-H","article-title":"Amplification of DNA sequences of Epstein-Barr and human immunodeficiency viruses using DNA-polymerase from Thermus thermophilus","volume":"4","author":"Glukhov","year":"1990","journal-title":"Mol Cell Probes"},{"key":"H16-5","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/1523-1747.ep12364814","article-title":"Skin-selective lymphocyte homing mechanisms in the pathogenesis of leukemic cutaneous T-cell lymphoma","volume":"101","author":"Heald","year":"1993","journal-title":"J Invest Dermatol"},{"key":"H17-5","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/0190-9622(95)90067-5","article-title":"CD8-positive tumor-infiltrating lymphocytes influence the long-term survival of patients with mycosis fungoides","volume":"32","author":"Hoppe","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"H18-5","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.1128\/JVI.75.12.5711-5718.2001","article-title":"PY motifs of Epstein-Barr virus LMP2A regulate protein stability and phosphorylation of LMP2A-associated proteins","volume":"75","author":"Ikeda","year":"2001","journal-title":"J Virol"},{"key":"H19-5","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1001\/archderm.1997.03890450023003","article-title":"Clinicopathologic manifestations of Epstein-Barr virus-associated cutaneous lymphoproliferative disorders","volume":"133","author":"Iwatsuki","year":"1997","journal-title":"Arch Dermatol"},{"key":"H20-5","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/(SICI)1521-4141(199802)28:02<451::AID-IMMU451>3.0.CO;2-U","article-title":"Identification of cytotoxic T cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 supertype-restricted immune recognition of EBV-infected cells by LMP1-specific cytotoxic T lymphocytes","volume":"28","author":"Khanna","year":"1998","journal-title":"Eur J Immunol"},{"key":"H21-5","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1182\/blood.V88.1.242.242","article-title":"Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlation with malignancy in Epstein-Barr virus-associated lymphoproliferative disorders and malignant lymphomas","volume":"88","author":"Kingma","year":"1996","journal-title":"Blood"},{"key":"H22-5","first-page":"580","article-title":"Molecular analysis of the LMP (latent membrane protein) oncogene in Hodgkin's disease","volume":"7","author":"Knecht","year":"1993","journal-title":"Leukemia"},{"key":"H23-5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/1523-1747.ep12485017","article-title":"Possible role of Epstein-Barr virus infection in cutaneous T-cell lymphomas","volume":"95","author":"Lee","year":"1990","journal-title":"J Invest Dermatol"},{"key":"H24-5","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0140-6736(96)91350-1","article-title":"Cutaneous T-cell lymphoma (mycosis fungoides)","volume":"347","author":"Lorincz","year":"1996","journal-title":"Lancet"},{"key":"H25-5","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1084\/jem.180.5.1973","article-title":"& 8 other authors","volume":"180","author":"Manca","year":"1994","journal-title":"J Exp Med"},{"key":"H26-5","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1099\/0022-1317-75-10-2729","article-title":"Sequence variation in the Epstein-Barr virus latent membrane protein 1","volume":"75","author":"Miller","year":"1994","journal-title":"J Gen Virol"},{"key":"H27-5","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/00042560-199612010-00003","article-title":"The difficulty of detecting HTLV-1 proviral sequences in patients with mycosis fungoides","volume":"13","author":"Pancake","year":"1996","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"H28-5","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1365-2133.1996.tb16235.x","article-title":"Detection of EBER nuclear RNA in T-cell lymphomas involving the skin \u2013an in situ hybridization study","volume":"134","author":"Park","year":"1996","journal-title":"Br J Dermatol"},{"key":"H29-5","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1128\/JVI.61.5.1310-1317.1987","article-title":"Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells","volume":"61","author":"Rickinson","year":"1987","journal-title":"J Virol"},{"key":"H30-5","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/1097-0215(200102)9999:9999<::AID-IJC1172>3.0.CO;2-O","article-title":"Expression of Epstein-Barr virus in cutaneous T-cell lymphoma including mycosis fungoides","volume":"92","author":"Shimakage","year":"2001","journal-title":"Int J Cancer"},{"key":"H31-5","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1200\/JCO.2000.18.15.2908","article-title":"Primary cutaneous T-cell lymphoma: review and current concepts","volume":"18","author":"Siegel","year":"2000","journal-title":"J Clin Oncol"},{"key":"H32-5","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/(SICI)1097-0215(19980413)76:2<207::AID-IJC7>3.0.CO;2-0","article-title":"Epstein-Barr virus strain variation in nasopharyngeal carcinoma from the endemic and non-endemic regions of China","volume":"76","author":"Sung","year":"1998","journal-title":"Int J Cancer"},{"key":"H33-5","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1086\/314672","article-title":"The molecular epidemiology and evolution of Epstein-Barr virus: sequence variation and genetic recombination in the latent membrane protein-1 gene","volume":"179","author":"Walling","year":"1999","journal-title":"J Infect Dis"}],"container-title":["Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jmm\/10.1099\/jmm.0.05439-0?crawler=true","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T02:09:28Z","timestamp":1705111768000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jmm\/10.1099\/jmm.0.05439-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5,1]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,5,1]]}},"URL":"https:\/\/doi.org\/10.1099\/jmm.0.05439-0","relation":{},"ISSN":["0022-2615","1473-5644"],"issn-type":[{"value":"0022-2615","type":"print"},{"value":"1473-5644","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,5,1]]}}}